Latent CMV And EBV Infections And The Mobilization Of Viral-specific And Senescent T-cells With Exercise

被引：0
|
作者：
Simpson, Richard J. [1 ]
Spielmann, Guillaume [1 ]
Bigley, Austin B. [1 ]
Rector, Jerrald L. [1 ]
Bartlett, David B. [1 ]
Morrison, Mark R. [1 ]
机构：
[1] Univ Houston, Houston, TX USA
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2011年 / 43卷 / 05期
关键词：
D O I：
10.1249/01.MSS.0000401343.81353.00
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
1943
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [21] CMV-specific and EBV-specific T cells for adoptive immunotherapy in viral diseases resistantto conventional therapies
    Martin-Donaire, T.
    Gonzalo-Daganzo, R. M.
    Sanchez, R.
    Gutierrez, Y.
    Garcia-Berciano, Y.
    Laiglesia, A.
    Regidor, C.
    Cabrera, J. R.
    HUMAN GENE THERAPY, 2013, 24 (12) : A170 - A170
  • [22] Generation of CD8+viral specific T cells from EBV and CMV naive individuals.
    Bao, Lei
    Niyazova-Brewer, Nargisa
    Dunham, Kimberly
    Kenneth, Kenneth
    Sun, Qi
    BLOOD, 2006, 108 (11) : 1044A - 1044A
  • [23] Viral-specific T cell infusions for refractory viral infections after allogeneic stem cell transplantation
    Lozano, Sara
    Pello, Oscar
    Loaiza, Sandra
    Woolley, Philippa
    Uddin, Shab
    Bray, Emma
    Ozbey, Kemal
    Nazir, Shaida
    Smith, Graham
    Thomas, Sinju
    Dlamini, Tsembayena
    Elio, Rosalinda
    Palanicawandar, Renuka
    Milojkovic, Dragana
    Pavlu, Jiri
    Kanfer, Edward
    Gabriel, Ian
    McDonald, Donald
    Jakob, Christian
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    Apperley, Jane
    Olavarria, Eduardo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 387 - 388
  • [24] Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
    Wei Jiang
    Barbara Withers
    Gaurav Sutrave
    Leighton E. Clancy
    Michelle I. Yong
    Emily Blyth
    Current Hematologic Malignancy Reports, 2019, 14 : 247 - 260
  • [25] Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
    Jiang, Wei
    Withers, Barbara
    Sutrave, Gaurav
    Clancy, Leighton E.
    Yong, Michelle I.
    Blyth, Emily
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (04) : 247 - 260
  • [26] Selective Depletion of Recipient-Alloreactive T-Cells While Retaining Viral-Specific and Memory T-Cells Enables Safe and Efficacious Haplo-Identical HSCT
    Velthuis, Jurjen H. L.
    De Jong, Liesbeth
    Boumedine, Radia Sidi
    Giard, Marie-Pier
    Roy, Denis-Claude
    Ruediger, Manfred
    BLOOD, 2014, 124 (21)
  • [27] SELECTIVE DEPLETION OF RECIPIENT-ALLOREACTIVE T-CELLS WHILE RETAINING VIRAL-SPECIFIC AND MEMORY T-CELLS ENABLES SAFE AND EFFICACIOUS HAPLO-IDENTICAL HSCT
    Velthuis, J.
    De Jong, L.
    Boumedine, R. S.
    Giard, M.
    Roy, D.
    Ruediger, M.
    CYTOTHERAPY, 2014, 16 (04) : S19 - S19
  • [28] SELECTIVE DEPLETION OF RECIPIENT-ALLOREACTIVE T-CELLS WHILE RETAINING VIRAL-SPECIFIC AND MEMORY T-CELLS ENABLES SAFE AND EFFICACIOUS HAPLO-IDENTICAL HSCT
    Velthuis, J.
    De Jong, L.
    Boumedine, R. Sidi
    Giard, M. -P.
    Roy, D. -C.
    Ruediger, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S127 - S128
  • [29] T-cells: Third Party Parity for Viral Infections
    O'Reilly, Richard J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (05): : 285 - 286
  • [30] A study of latent CMV viral load and CD8+CMV-specific T cells responses in patients with CLL by stage of disease
    Parry, Helen
    Pratt, Guy
    Zuo, Jianmin
    Mirajkar, Mikhail
    Griffiths, Mike
    Moss, Paul
    LEUKEMIA & LYMPHOMA, 2017, 58 : 195 - 195
12345